Site to Provide Glucotrace (Fluorodeoxyglucose) for Use in Earlier Detection of Disease and Therapy Management OTTAWA and FLEURUS, Belgium, May...
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...
OTTAWA, May 19 /PRNewswire-FirstCall/ -- MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has received information...
OTTAWA, May 4 /PRNewswire-FirstCall/ -- MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular...
KING OF PRUSSIA, PA, April 28 /PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider of innovative drug discovery and development...
Enhancements Increase Flexibility and High-Content Screening Throughput SUNNYVALE, CA, April 27 /PRNewswire-FirstCall/ -- MDS Analytical...
SUNNYVALE, CA, April 16 /PRNewswire-FirstCall/ -- MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life...
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS...
TORONTO, March 18 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.